BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6177167)

  • 21. [The effect of fluocortin butylester on adrenal function in man (author's transl)].
    Wendt H
    Arzneimittelforschung; 1977; 27(11a):2236-8. PubMed ID: 580036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
    Sequira J; Berardi M; Chan TM; Letarte J; Malchow R; Pramanick B; Wolkoff HN
    Clin Ther; 1991; 13(6):687-94. PubMed ID: 1790543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-halogenated glucocorticoids in the treatment of psoriasis].
    Tølløfsrud A; Malmsten LA
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):560-1. PubMed ID: 6760456
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative toxicity study of hydrocortisone 17-butyrate 21-propionate (HBP) ointment and other topical corticosteroids in rats.
    Kimura M; Tarumoto Y; Nakane S; Otomo S
    Drugs Exp Clin Res; 1986; 12(8):643-52. PubMed ID: 3757761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study.
    Synnerstad B; Lindqvist N
    Br J Clin Pract; 1996; 50(7):363-6. PubMed ID: 9015907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids.
    Meibohm B; Derendorf H; Möllmann H; Fröhlich P; Tromm A; Wagner M; Homrighausen S; Krieg M; Hochhaus G
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):367-76. PubMed ID: 10475139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind trial of budesonide and betamethasone- 17,21-dipropionate in psoriasis.
    Fredriksson T; Salde L
    Curr Med Res Opin; 1982; 8(3):171-7. PubMed ID: 6751704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The antiinflammatory effect of budesonide ointment and cream].
    Hiroi J; Fujii T; Satoh S; Yoneda K; Senoh H; Mori J; Kikuchi H
    Nihon Yakurigaku Zasshi; 1985 Sep; 86(3):233-9. PubMed ID: 4085930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of betamethasone dipropionate glycol ointment 0.05% (diprosone O.V.) on adrenocortical function.
    Downie DA; Swarbrick PT; Salmon RM
    Australas J Dermatol; 1981 Dec; 22(3):113-8. PubMed ID: 7344689
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 32. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
    Allenby CF; Sparkes CG
    Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of topical glucocorticoids on endogenous cortisol production].
    Neumann RA; Schmidt JB; Spona J
    Z Hautkr; 1988 Apr; 63(4):302-8. PubMed ID: 3291439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic effects of topically applied methylprednisolone aceponate in healthy volunteers.
    Kecskés A; Jahn P; Matthes H; Kuhlmann RK; Lange L
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):789-92. PubMed ID: 8496431
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of the external use of triamcinolone acetonide under foil occlussive dressings on the plasma cortisol level and on the diurnal rhythm of plasma cortisol].
    Hartmann F; Lahmann JJ
    Hautarzt; 1977 Apr; 28(4):198-202. PubMed ID: 559653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of potent topical corticosteroids on adrenocortical function.
    Aso M
    J Dermatol; 1983 Apr; 10(2):145-9. PubMed ID: 6352764
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of occlusive tape systems on the mitotic activity of epidermis. With and without corticosteroids.
    Fisher LB; Maibach HI; Trancik RJ
    Arch Dermatol; 1978 Mar; 114(3):384-6. PubMed ID: 629573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local antiphlogistic treatment with Apulein cream.
    Garamvölgyi G
    Ther Hung; 1992; 40(4):163-5. PubMed ID: 1345022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rapidity of the effect of different types of topical corticosteroids: a double-blind comparison between Diproderm ointment 0.05 percent and Calmuril-Hydrocortisone 1 percent.
    Gip L; Karltorp N
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):300-5. PubMed ID: 4208345
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trial of a potent non-halogenated topical steroid, Budesonide.
    Agrup G; Björnberg A; Elmros T; Groth O; Hannuksela M; Lassus A; Salde L; Skogh M; Thomsen K
    Acta Derm Venereol; 1981; 61(2):180-2. PubMed ID: 6165205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.